Vicinitas Therapeutics
PrivateLast Round
Series A
Jul 28, 2022
Total Funding Raised
$65M
Company Overview
Vicinitas Therapeutics is a biotechnology company that develops novel therapeutics for cancer and genetic disorders using its proprietary Deubiquitinase Targeting Chimeras (DUBTACs) protein stabilization platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vicinitas Therapeutics Comparables
Compare Vicinitas Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stablix | 93% | |
| Entact Bio | 83% | |
| UbiquiTx | 76% |
Vicinitas Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 28, 2022 |
Vicinitas Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A |
| Deerfield Management | Series A |
| GV | Series A |
| Droia Ventures | Series A |
| Berkeley Catalyst Fund | Series A |
| The Mark Foundation for Cancer Research | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2022
$65M round led by Andreessen Horowitz and Deerfield Management.
Vicinitas Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vicinitas Therapeutics's valuation, stock price, and market status.
Is Vicinitas Therapeutics a public or private company?
Vicinitas Therapeutics is a private company.
What is the current stock price of Vicinitas Therapeutics?
Vicinitas Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Vicinitas Therapeutics worth (valuation)?
Valuation information for Vicinitas Therapeutics is not publicly available.
Can I buy Vicinitas Therapeutics stock?
Vicinitas Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Vicinitas Therapeutics's last funding round?
Vicinitas Therapeutics's most recent funding round was Series A on July 28, 2022.
Who are the main investors in Vicinitas Therapeutics?
Key investors in Vicinitas Therapeutics include Andreessen Horowitz, Deerfield Management.
Will Vicinitas Therapeutics IPO soon?
No public IPO plans have been announced for Vicinitas Therapeutics.
How can I track Vicinitas Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vicinitas Therapeutics's secondary market activity and sign up for updates.